About Alzamend Neuro (ALZN)
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic ... Read more
- USD3.23
- USD3.60
- USD3.15
- USD135.54
- -2.20%
- --
- 477.84k
- 548.25k
- 3M
- 2.75
- -90.60%
Stock News
3 hours ago
Wall Street braces for Treasury to try lowering 10-year yields with more buybacks. The problem? It could backfire.
MarketWatch
4 hours ago
Why Jim Cramer is ready to sell more of the portfolio's sole oil and nat gas stock
CNBC
5 hours ago
The 21st Annual LDC Gas Forum Energy Innovations Rockies & West takes place in Denver, CO August 11 - 13, 2025
Yahoo
7 hours ago
The ‘lock-in effect’ is making it harder to buy a home—even if mortgage rates fall
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
